These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17258210)

  • 1. MAPPIT analysis of TLR adaptor complexes.
    Ulrichts P; Peelman F; Beyaert R; Tavernier J
    FEBS Lett; 2007 Feb; 581(4):629-36. PubMed ID: 17258210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAPPIT analysis of early Toll-like receptor signalling events.
    Ulrichts P; Tavernier J
    Immunol Lett; 2008 Mar; 116(2):141-8. PubMed ID: 18221795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspase-1 targets the TLR adaptor Mal at a crucial TIR-domain interaction site.
    Ulrichts P; Bovijn C; Lievens S; Beyaert R; Tavernier J; Peelman F
    J Cell Sci; 2010 Jan; 123(Pt 2):256-65. PubMed ID: 20048342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic zebrafish reporter lines reveal conserved Toll-like receptor signaling potential in embryonic myeloid leukocytes and adult immune cell lineages.
    Hall C; Flores MV; Chien A; Davidson A; Crosier K; Crosier P
    J Leukoc Biol; 2009 May; 85(5):751-65. PubMed ID: 19218482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.
    O'Neill LA; Bowie AG
    Nat Rev Immunol; 2007 May; 7(5):353-64. PubMed ID: 17457343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6.
    Häcker H; Redecke V; Blagoev B; Kratchmarova I; Hsu LC; Wang GG; Kamps MP; Raz E; Wagner H; Häcker G; Mann M; Karin M
    Nature; 2006 Jan; 439(7073):204-7. PubMed ID: 16306937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sorting out Toll signals.
    Fitzgerald KA; Chen ZJ
    Cell; 2006 Jun; 125(5):834-6. PubMed ID: 16751092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.
    Lang T; Lo C; Skinner N; Locarnini S; Visvanathan K; Mansell A
    J Hepatol; 2011 Oct; 55(4):762-9. PubMed ID: 21334391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors and adaptor molecules in liver disease: update.
    Seki E; Brenner DA
    Hepatology; 2008 Jul; 48(1):322-35. PubMed ID: 18506843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Troll in Toll: Mal and Tram as bridges for TLR2 and TLR4 signaling.
    Sheedy FJ; O'Neill LA
    J Leukoc Biol; 2007 Aug; 82(2):196-203. PubMed ID: 17449723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive map of the toll-like receptor signaling network.
    Oda K; Kitano H
    Mol Syst Biol; 2006; 2():2006.0015. PubMed ID: 16738560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors.
    Hara H; Ishihara C; Takeuchi A; Imanishi T; Xue L; Morris SW; Inui M; Takai T; Shibuya A; Saijo S; Iwakura Y; Ohno N; Koseki H; Yoshida H; Penninger JM; Saito T
    Nat Immunol; 2007 Jun; 8(6):619-29. PubMed ID: 17486093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase Cdelta binds TIRAP/Mal to participate in TLR signaling.
    Kubo-Murai M; Hazeki K; Sukenobu N; Yoshikawa K; Nigorikawa K; Inoue K; Yamamoto T; Matsumoto M; Seya T; Inoue N; Hazeki O
    Mol Immunol; 2007 Mar; 44(9):2257-64. PubMed ID: 17161867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor recognition regulates immunodominance in an antimicrobial CD4+ T cell response.
    Yarovinsky F; Kanzler H; Hieny S; Coffman RL; Sher A
    Immunity; 2006 Oct; 25(4):655-64. PubMed ID: 17000122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MyDths and un-TOLLed truths: sensor, instructive and effector immunity to tuberculosis.
    Reiling N; Ehlers S; Hölscher C
    Immunol Lett; 2008 Feb; 116(1):15-23. PubMed ID: 18191460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct roles of TIR and non-TIR regions in the subcellular localization and signaling properties of MyD88.
    Nishiya T; Kajita E; Horinouchi T; Nishimoto A; Miwa S
    FEBS Lett; 2007 Jul; 581(17):3223-9. PubMed ID: 17583698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.
    Xu H; An H; Hou J; Han C; Wang P; Yu Y; Cao X
    Mol Immunol; 2008 Aug; 45(13):3545-52. PubMed ID: 18571728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial lipopolysaccharide induces increased expression of toll-like receptor (TLR) 4 and downstream TLR signaling molecules in bovine mammary epithelial cells.
    Ibeagha-Awemu EM; Lee JW; Ibeagha AE; Bannerman DD; Paape MJ; Zhao X
    Vet Res; 2008; 39(2):11. PubMed ID: 18096120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
    Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
    Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis.
    Jiang Z; Georgel P; Li C; Choe J; Crozat K; Rutschmann S; Du X; Bigby T; Mudd S; Sovath S; Wilson IA; Olson A; Beutler B
    Proc Natl Acad Sci U S A; 2006 Jul; 103(29):10961-6. PubMed ID: 16832055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.